Ozempic and Wegovy force weight loss companies to upend their approaches

  • 📰 NBCNews
  • ⏱ Reading Time:
  • 39 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 86%

Brasil Notícia Notícia

Brasil Últimas Notícias,Brasil Manchetes

The growing popularity of obesity and diabetes drugs Wegovy and Ozempic is inspiring other weight-loss companies to fundamentally shift their business models.

, a telehealth company that offers prescriptions for obesity drugs. In the coming months, WeightWatchers said it would roll out a program for members taking the medications.

Dr. Gary Foster, chief scientific officer at WeightWatchers, similarly said that offering medication was a"natural next step" for the company. "What these drugs have really shown us is that obesity is a metabolic biological problem. You can’t just overcome it with lifestyle interventions, for the most part," said Dr. Eduardo Grunvald, an obesity medicine physician at UC San Diego Health.

Dr. Spencer Nadolsky, Sequence's medical director, said some people have difficulties obtaining the drugs because some general practitioners are not yet comfortable prescribing them. "Taking these weight-loss medications has validated what I knew: that my body was working against me, and that I wasn’t broken," Wood said in an email.

 

Obrigado pelo seu comentário. Seu comentário será publicado após ser revisado.
Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

 /  🏆 10. in BR

Brasil Últimas Notícias, Brasil Manchetes